Skip to main content
Top
Published in: Breast Cancer Research 1/2018

Open Access 01-12-2018 | Research article

Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)

Authors: John L. Hopper, Gillian S. Dite, Robert J. MacInnis, Yuyan Liao, Nur Zeinomar, Julia A. Knight, Melissa C. Southey, Roger L. Milne, Wendy K. Chung, Graham G. Giles, Jeanine M. Genkinger, Sue-Anne McLachlan, Michael L. Friedlander, Antonis C. Antoniou, Prue C. Weideman, Gord Glendon, Stephanie Nesci, Irene L. Andrulis, Saundra S. Buys, Mary B. Daly, Esther M. John, Kelly Anne Phillips, Mary Beth Terry, kConFab Investigators

Published in: Breast Cancer Research | Issue 1/2018

Login to get access

Abstract

Background

The association between body mass index (BMI) and risk of breast cancer depends on time of life, but it is unknown whether this association depends on a woman’s familial risk.

Methods

We conducted a prospective study of a cohort enriched for familial risk consisting of 16,035 women from 6701 families in the Breast Cancer Family Registry and the Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer followed for up to 20 years (mean 10.5 years). There were 896 incident breast cancers (mean age at diagnosis 55.7 years). We used Cox regression to model BMI risk associations as a function of menopausal status, age, and underlying familial risk based on pedigree data using the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA), all measured at baseline.

Results

The strength and direction of the BMI risk association depended on baseline menopausal status (P < 0.001); after adjusting for menopausal status, the association did not depend on age at baseline (P = 0.6). In terms of absolute risk, the negative association with BMI for premenopausal women has a much smaller influence than the positive association with BMI for postmenopausal women. Women at higher familial risk have a much larger difference in absolute risk depending on their BMI than women at lower familial risk.

Conclusions

The greater a woman’s familial risk, the greater the influence of BMI on her absolute postmenopausal breast cancer risk. Given that age-adjusted BMI is correlated across adulthood, maintaining a healthy weight throughout adult life is particularly important for women with a family history of breast cancer.
Literature
1.
go back to reference Baer HJ, Tworoger SS, Hankinson SE, Willett WC. Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol. 2010;171(11):1183–94.CrossRef Baer HJ, Tworoger SS, Hankinson SE, Willett WC. Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol. 2010;171(11):1183–94.CrossRef
2.
go back to reference Bandera EV, Chandran U, Zirpoli G, Ciupak G, Bovbjerg DH, Jandorf L, et al. Body size in early life and breast cancer risk in African American and European American women. Cancer Causes Control. 2013;24(12):2231–43.CrossRef Bandera EV, Chandran U, Zirpoli G, Ciupak G, Bovbjerg DH, Jandorf L, et al. Body size in early life and breast cancer risk in African American and European American women. Cancer Causes Control. 2013;24(12):2231–43.CrossRef
3.
go back to reference Bardia A, Vachon CM, Olson JE, Vierkant RA, Wang AH, Hartmann LC, et al. Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev. 2008;17(2):374–8.CrossRef Bardia A, Vachon CM, Olson JE, Vierkant RA, Wang AH, Hartmann LC, et al. Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev. 2008;17(2):374–8.CrossRef
4.
go back to reference Berkey CS, Frazier AL, Gardner JD, Colditz GA. Adolescence and breast carcinoma risk. Cancer. 1999;85(11):2400–9.CrossRef Berkey CS, Frazier AL, Gardner JD, Colditz GA. Adolescence and breast carcinoma risk. Cancer. 1999;85(11):2400–9.CrossRef
5.
go back to reference Bodicoat DH, Schoemaker MJ, Jones ME, McFadden E, Griffin J, Ashworth A, et al. Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study. Breast Cancer Res. 2014;16(1):R18.CrossRef Bodicoat DH, Schoemaker MJ, Jones ME, McFadden E, Griffin J, Ashworth A, et al. Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study. Breast Cancer Res. 2014;16(1):R18.CrossRef
6.
go back to reference Robinson WR, Tse CK, Olshan AF, Troester MA. Body size across the life course and risk of premenopausal and postmenopausal breast cancer in Black women, the Carolina Breast Cancer Study, 1993-2001. Cancer Causes Control. 2014;25(9):1101–17.CrossRef Robinson WR, Tse CK, Olshan AF, Troester MA. Body size across the life course and risk of premenopausal and postmenopausal breast cancer in Black women, the Carolina Breast Cancer Study, 1993-2001. Cancer Causes Control. 2014;25(9):1101–17.CrossRef
7.
go back to reference Rosner B, Eliassen AH, Toriola AT, Chen WY, Hankinson SE, Willett WC, et al. Weight and weight changes in early adulthood and later breast cancer risk. Int J Cancer. 2017;140(9):2003–14.CrossRef Rosner B, Eliassen AH, Toriola AT, Chen WY, Hankinson SE, Willett WC, et al. Weight and weight changes in early adulthood and later breast cancer risk. Int J Cancer. 2017;140(9):2003–14.CrossRef
8.
go back to reference Shawon SR, Eriksson M, Li J. Body size in early life and risk of breast cancer. Breast Cancer Res. 2017;19(1):84.CrossRef Shawon SR, Eriksson M, Li J. Body size in early life and risk of breast cancer. Breast Cancer Res. 2017;19(1):84.CrossRef
9.
10.
go back to reference Baer HJ, Colditz GA, Rosner B, Michels KB, Rich-Edwards JW, Hunter DJ, et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res. 2005;7(3):R314–25.CrossRef Baer HJ, Colditz GA, Rosner B, Michels KB, Rich-Edwards JW, Hunter DJ, et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res. 2005;7(3):R314–25.CrossRef
11.
go back to reference Coates RJ, Uhler RJ, Hall HI, Potischman N, Brinton LA, Ballard-Barbash R, et al. Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. Br J Cancer. 1999;81(1):167–74.CrossRef Coates RJ, Uhler RJ, Hall HI, Potischman N, Brinton LA, Ballard-Barbash R, et al. Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. Br J Cancer. 1999;81(1):167–74.CrossRef
12.
go back to reference Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006;166(21):2395–402.CrossRef Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006;166(21):2395–402.CrossRef
13.
go back to reference Weiderpass E, Braaten T, Magnusson C, Kumle M, Vainio H, Lund E, et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomark Prev. 2004;13(7):1121–7. Weiderpass E, Braaten T, Magnusson C, Kumle M, Vainio H, Lund E, et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomark Prev. 2004;13(7):1121–7.
14.
go back to reference John EM, Sangaramoorthy M, Hines LM, Stern MC, Baumgartner KB, Giuliano AR, et al. Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomark Prev. 2015;24(1):128–37.CrossRef John EM, Sangaramoorthy M, Hines LM, Stern MC, Baumgartner KB, Giuliano AR, et al. Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomark Prev. 2015;24(1):128–37.CrossRef
15.
go back to reference Bandera EV, Maskarinec G, Romieu I, John EM. Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective. Adv Nutr. 2015;6(6):803–19.CrossRef Bandera EV, Maskarinec G, Romieu I, John EM. Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective. Adv Nutr. 2015;6(6):803–19.CrossRef
16.
go back to reference MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev. 2004;13(12):2117–25. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev. 2004;13(12):2117–25.
17.
go back to reference John EM, Phipps AI, Sangaramoorthy M. Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Springerplus. 2013;24(1):239.CrossRef John EM, Phipps AI, Sangaramoorthy M. Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Springerplus. 2013;24(1):239.CrossRef
18.
go back to reference Gao C, Patel CJ, Michailidou K, Peters U, Gong J, Schildkraut J, et al. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int J Epidemiol. 2016;45(3):896–908.CrossRef Gao C, Patel CJ, Michailidou K, Peters U, Gong J, Schildkraut J, et al. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int J Epidemiol. 2016;45(3):896–908.CrossRef
19.
go back to reference Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, et al. Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent. PLoS Med. 2016;13(8):e1002105.CrossRef Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, et al. Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent. PLoS Med. 2016;13(8):e1002105.CrossRef
20.
go back to reference Hopper JL, Carlin JB. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol. 1992;136(9):1138–47.CrossRef Hopper JL, Carlin JB. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol. 1992;136(9):1138–47.CrossRef
21.
go back to reference Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107(5):djv036.CrossRef Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107(5):djv036.CrossRef
22.
go back to reference Dite GS, Macinnis RJ, Bickerstaffe A, Dowty JG, Allman R, Apicella C, et al. Breast cancer risk prediction using clinical models and 77 independent risk-associated SNPs for women aged under 50 years: Australian Breast Cancer Family Registry. Cancer Epidemiol Biomark Prev. 2016;25(2):359–65.CrossRef Dite GS, Macinnis RJ, Bickerstaffe A, Dowty JG, Allman R, Apicella C, et al. Breast cancer risk prediction using clinical models and 77 independent risk-associated SNPs for women aged under 50 years: Australian Breast Cancer Family Registry. Cancer Epidemiol Biomark Prev. 2016;25(2):359–65.CrossRef
23.
go back to reference Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med. 2015;372(23):2243–57.CrossRef Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med. 2015;372(23):2243–57.CrossRef
24.
go back to reference Nguyen-Dumont T, Teo ZL, Pope BJ, Hammet F, Mahmoodi M, Tsimiklis H, et al. Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2. BMC Med Genet. 2013;6:48. Nguyen-Dumont T, Teo ZL, Pope BJ, Hammet F, Mahmoodi M, Tsimiklis H, et al. Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2. BMC Med Genet. 2013;6:48.
25.
go back to reference Nguyen-Dumont T, Mahmoodi M, Hammet F, Tran T, Tsimiklis H, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, et al. Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots. Anal Biochem. 2015;470:48–51.CrossRef Nguyen-Dumont T, Mahmoodi M, Hammet F, Tran T, Tsimiklis H, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, et al. Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots. Anal Biochem. 2015;470:48–51.CrossRef
26.
go back to reference Hopper JL. Genetics for population and public health. Int J Epidemiol. 2017;46(1):8–11.CrossRef Hopper JL. Genetics for population and public health. Int J Epidemiol. 2017;46(1):8–11.CrossRef
27.
go back to reference Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Winkins; 2013. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Winkins; 2013.
28.
go back to reference Terry MB, Phillips KA, Daly MB, John EM, Andrulis IL, Buys SS, et al. Cohort profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC). Int J Epidemiol. 2016;45(3):683–92.CrossRef Terry MB, Phillips KA, Daly MB, John EM, Andrulis IL, Buys SS, et al. Cohort profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC). Int J Epidemiol. 2016;45(3):683–92.CrossRef
29.
go back to reference John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 2004;6(4):R375–89.CrossRef John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 2004;6(4):R375–89.CrossRef
30.
go back to reference Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res. 2006;8(1):R12.CrossRef Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res. 2006;8(1):R12.CrossRef
31.
go back to reference Phillips KA, Butow PN, Stewart AE, Chang JH, Weideman PC, Price MA, et al. Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Familial Cancer. 2005;4(2):105–13.CrossRef Phillips KA, Butow PN, Stewart AE, Chang JH, Weideman PC, Price MA, et al. Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Familial Cancer. 2005;4(2):105–13.CrossRef
32.
go back to reference Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, et al. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat. 2009;116(2):379–86.CrossRef Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, et al. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat. 2009;116(2):379–86.CrossRef
33.
go back to reference McCredie MR, Dite GS, Giles GG, Hopper JL. Breast cancer in Australian women under the age of 40. Cancer Causes Control. 1998;9(2):189–98.CrossRef McCredie MR, Dite GS, Giles GG, Hopper JL. Breast cancer in Australian women under the age of 40. Cancer Causes Control. 1998;9(2):189–98.CrossRef
34.
go back to reference Hopper JL, Giles GG, McCredie MRE, Boyle P. Background, rationale and protocol for a case-control-family study of breast cancer. Breast. 1994;3(2):79–86.CrossRef Hopper JL, Giles GG, McCredie MRE, Boyle P. Background, rationale and protocol for a case-control-family study of breast cancer. Breast. 1994;3(2):79–86.CrossRef
35.
go back to reference Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98(8):1457–66.CrossRef Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98(8):1457–66.CrossRef
36.
go back to reference Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004;91(8):1580–90.CrossRef Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004;91(8):1580–90.CrossRef
38.
go back to reference Dite GS, Whittemore AS, Knight JA, John EM, Milne RL, Andrulis IL, et al. Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. Br J Cancer. 2010;103(7):1103–8.CrossRef Dite GS, Whittemore AS, Knight JA, John EM, Milne RL, Andrulis IL, et al. Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. Br J Cancer. 2010;103(7):1103–8.CrossRef
39.
go back to reference StataCorp. Stata Statistical Software, Release 14. College Station: StataCorp LP; 2015. StataCorp. Stata Statistical Software, Release 14. College Station: StataCorp LP; 2015.
40.
go back to reference Surveillance Epidemiology and End Results (SEER) Program. SEER*stat database: incidence - SEER 13 regs research data, Nov 2011 Sub (1992–2009) <Katrina/Rita Population Adjustment> − Linked To County Attributes - Total U.S.; 2011. Surveillance Epidemiology and End Results (SEER) Program. SEER*stat database: incidence - SEER 13 regs research data, Nov 2011 Sub (1992–2009) <Katrina/Rita Population Adjustment> − Linked To County Attributes - Total U.S.; 2011.
41.
go back to reference Surveillance Epidemiology and End Results (SEER) Program. SEER*stat database: incidence - SEER 18 regs research data, Nov 2011 Sub (2000–2009) <Katrina/Rita Population Adjustment> − Linked To County Attributes - Total U.S.; 2011. Surveillance Epidemiology and End Results (SEER) Program. SEER*stat database: incidence - SEER 18 regs research data, Nov 2011 Sub (2000–2009) <Katrina/Rita Population Adjustment> − Linked To County Attributes - Total U.S.; 2011.
42.
go back to reference Surveillance Epidemiology and End Results (SEER) Program. SEER*stat database: incidence - SEER 9 regs research data, Nov 2011 Sub (1973–2009) <Katrina/Rita Population Adjustment> − Linked To County Attributes - Total U.S.; 2011. Surveillance Epidemiology and End Results (SEER) Program. SEER*stat database: incidence - SEER 9 regs research data, Nov 2011 Sub (1973–2009) <Katrina/Rita Population Adjustment> − Linked To County Attributes - Total U.S.; 2011.
43.
go back to reference Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC, et al. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. Br J Cancer. 2014;110(2):535–45.CrossRef Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC, et al. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. Br J Cancer. 2014;110(2):535–45.CrossRef
44.
go back to reference Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev. 2013;14(8):665–78.CrossRef Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev. 2013;14(8):665–78.CrossRef
45.
go back to reference Dite GS, MacInnis RJ, Bickerstaffe A, Dowty JG, Milne RL, Antoniou AC, et al. Testing for gene-environment interactions using a prospective family cohort design: body mass index in early and later adulthood and risk of breast cancer. Am J Epidemiol. 2017;185(6):487–500.CrossRef Dite GS, MacInnis RJ, Bickerstaffe A, Dowty JG, Milne RL, Antoniou AC, et al. Testing for gene-environment interactions using a prospective family cohort design: body mass index in early and later adulthood and risk of breast cancer. Am J Epidemiol. 2017;185(6):487–500.CrossRef
46.
go back to reference Shen J, Liao Y, Hopper JL, Goldberg M, Santella RM, Terry MB. Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer. Br J Cancer. 2017;116(9):1229–33.CrossRef Shen J, Liao Y, Hopper JL, Goldberg M, Santella RM, Terry MB. Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer. Br J Cancer. 2017;116(9):1229–33.CrossRef
47.
go back to reference Quante AS, Herz J, Whittemore AS, Fischer C, Strauch K, Terry MB. Assessing absolute changes in breast cancer risk due to modifiable risk factors. Breast Cancer Res Treat. 2015;152(1):193–7.CrossRef Quante AS, Herz J, Whittemore AS, Fischer C, Strauch K, Terry MB. Assessing absolute changes in breast cancer risk due to modifiable risk factors. Breast Cancer Res Treat. 2015;152(1):193–7.CrossRef
48.
go back to reference Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk. J Natl Cancer Inst. 2015;107(7):djv124.CrossRef Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk. J Natl Cancer Inst. 2015;107(7):djv124.CrossRef
49.
go back to reference Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benitez J, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res. 2010;12(6):R110.CrossRef Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benitez J, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res. 2010;12(6):R110.CrossRef
50.
go back to reference Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.CrossRef Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.CrossRef
51.
go back to reference Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2014;36:114–36.CrossRef Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2014;36:114–36.CrossRef
52.
go back to reference Ma H, Ursin G, Xu X, Lee E, Togawa K, Malone KE, et al. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. Breast Cancer Res. 2018;20(1):5.CrossRef Ma H, Ursin G, Xu X, Lee E, Togawa K, Malone KE, et al. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. Breast Cancer Res. 2018;20(1):5.CrossRef
53.
go back to reference Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, et al. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nat Commun. 2013;4:1449.CrossRef Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, et al. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nat Commun. 2013;4:1449.CrossRef
54.
go back to reference Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis. 2004;25(5):741–8.CrossRef Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis. 2004;25(5):741–8.CrossRef
55.
go back to reference Sherratt MJ, McConnell JC, Streuli CH. Raised mammographic density: causative mechanisms and biological consequences. Breast Cancer Res. 2016;18(1):45.CrossRef Sherratt MJ, McConnell JC, Streuli CH. Raised mammographic density: causative mechanisms and biological consequences. Breast Cancer Res. 2016;18(1):45.CrossRef
56.
go back to reference Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378–97. Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378–97.
57.
go back to reference Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45(1 Suppl):277–82.CrossRef Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45(1 Suppl):277–82.CrossRef
58.
go back to reference Hudis C, Dannenberg A. Obesity and breast cancer: narrowing the focus. JAMA Oncol. 2015;1(5):622–3.CrossRef Hudis C, Dannenberg A. Obesity and breast cancer: narrowing the focus. JAMA Oncol. 2015;1(5):622–3.CrossRef
59.
go back to reference Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016;34(35):4270–6.CrossRef Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016;34(35):4270–6.CrossRef
60.
go back to reference Ester WA, Houghton LC, Lumey LH, Michels KB, Hoek HW, Wei Y, et al. Maternal and early childhood determinants of women's body size in midlife: overall cohort and sibling analyses. Am J Epidemiol. 2017;185(5):1–10.CrossRef Ester WA, Houghton LC, Lumey LH, Michels KB, Hoek HW, Wei Y, et al. Maternal and early childhood determinants of women's body size in midlife: overall cohort and sibling analyses. Am J Epidemiol. 2017;185(5):1–10.CrossRef
Metadata
Title
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)
Authors
John L. Hopper
Gillian S. Dite
Robert J. MacInnis
Yuyan Liao
Nur Zeinomar
Julia A. Knight
Melissa C. Southey
Roger L. Milne
Wendy K. Chung
Graham G. Giles
Jeanine M. Genkinger
Sue-Anne McLachlan
Michael L. Friedlander
Antonis C. Antoniou
Prue C. Weideman
Gord Glendon
Stephanie Nesci
Irene L. Andrulis
Saundra S. Buys
Mary B. Daly
Esther M. John
Kelly Anne Phillips
Mary Beth Terry
kConFab Investigators
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2018
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-018-1056-1

Other articles of this Issue 1/2018

Breast Cancer Research 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine